These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38437542)

  • 1. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles.
    Francia V; Zhang Y; Cheng MHY; Schiffelers RM; Witzigmann D; Cullis PR
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307803120. PubMed ID: 38437542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
    Francia V; Schiffelers RM; Cullis PR; Witzigmann D
    Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro.
    van Straten D; Sork H; van de Schepop L; Frunt R; Ezzat K; Schiffelers RM
    J Control Release; 2024 Sep; 373():481-492. PubMed ID: 39032575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
    Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
    Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities.
    Simonsen JB
    J Control Release; 2024 Jun; 370():763-772. PubMed ID: 38621638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
    Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
    ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo.
    Münter R; Larsen JB; Andresen TL
    J Colloid Interface Sci; 2024 Nov; 674():139-144. PubMed ID: 38925059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a fast and simple method for the isolation of superparamagnetic iron oxide nanoparticles protein corona from protein-rich matrices.
    Soliman MG; Trinh DN; Ravagli C; Meleady P; Henry M; Movia D; Doumett S; Cappiello L; Prina-Mello A; Baldi G; Monopoli MP
    J Colloid Interface Sci; 2024 Apr; 659():503-519. PubMed ID: 38184993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
    Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device.
    Maeki M; Okada Y; Uno S; Niwa A; Ishida A; Tani H; Tokeshi M
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput
    Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
    ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
    Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
    Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
    Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles.
    Sebastiani F; Yanez Arteta M; Lerche M; Porcar L; Lang C; Bragg RA; Elmore CS; Krishnamurthy VR; Russell RA; Darwish T; Pichler H; Waldie S; Moulin M; Haertlein M; Forsyth VT; Lindfors L; Cárdenas M
    ACS Nano; 2021 Apr; 15(4):6709-6722. PubMed ID: 33754708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.
    Geisler HC; Ghalsasi AA; Safford HC; Swingle KL; Thatte AS; Mukalel AJ; Gong N; Hamilton AG; Han EL; Nachod BE; Padilla MS; Mitchell MJ
    J Control Release; 2024 Jul; 371():455-469. PubMed ID: 38789090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles.
    Dilliard SA; Sun Y; Brown MO; Sung YC; Chatterjee S; Farbiak L; Vaidya A; Lian X; Wang X; Lemoff A; Siegwart DJ
    J Control Release; 2023 Sep; 361():361-372. PubMed ID: 37536547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
    Cui L; Pereira S; Sonzini S; van Pelt S; Romanelli SM; Liang L; Ulkoski D; Krishnamurthy VR; Brannigan E; Brankin C; Desai AS
    Nanoscale; 2022 Jan; 14(4):1480-1491. PubMed ID: 35024714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.